Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials

Verstovsek, S; Mesa, R; Gupta, V; Lavie, D; Dubruille, V; Cambier, N; Platzbecker, U; Hus, M; Xicoy, B; Oh, ST; Kiladjian, JJ; Vannucchi, AM; Gerds, A; Egyed, M; Mayer, J; Sacha, T; Kawashima, J; Morris, M; Huang, M; Harrison, C

Verstovsek, S (通讯作者)，275 Shoreline Dr, Suite 300, Redwood City, CA 94065 USA.

BLOOD ADVANCES, 2023; 7 (14): 3582

Abstract

Momelotinib is the first inhibitor of Janus kinase 1 (JAK1) and JAK2 shown to also inhibit activin A receptor type 1 (ACVR1), a key regulator of iron ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索